RecruitingPhase 3NCT06133972
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Sponsor: Novartis Pharmaceuticals
Baltimore, MD · +24 more sites
Lupus clinical trials in Baltimore, MD
6 recruiting lupus studies with a site in Baltimore, MD.
RecruitingPhase 1NCT03816345
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Sponsor: National Cancer Institute (NCI)
Baltimore, MD · Bethesda, MD · +48 more sites
RecruitingPhase 1 / Phase 2NCT06897930
A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
Sponsor: AstraZeneca
Baltimore, MD · Bethesda, MD · +14 more sites
RecruitingPhase 1NCT07085104
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Sponsor: Allogene Therapeutics
Baltimore, MD · +15 more sites
RecruitingPhase not listedNCT06527872
Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN
Sponsor: GlaxoSmithKline
Baltimore, MD · +3 more sites
RecruitingPhase not listedNCT00198068
Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
Sponsor: Hospital for Special Surgery, New York
Baltimore, MD · +7 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.